why choose us

First received: October 20, 2023

Clinical Trial: Clinical Trial to Assess Effect of Verapamil on Systemic Exposure of EP395 and Effect of EP395 on Systemic Exposure of Midazolam and Digoxin

Study Status: Completed

Recruit Status: RECRUITING

Condition: Chronic Obstructive Pulmonary Disease Exacerbation

Study Type: INTERVENTIONAL


Official Title: An Open-label, Healthy Subject, Two-part Study to Assess the Effect of Verapamil on Systemic Exposure of EP395 (Part A), and to Assess the Effect of EP395 on Systemic Exposure of Midazolam and Digoxin

Brief Summary: The aim of this trial is to assess the potential key drug-drug interactions with EP395 in the clinical setting.

Read more